Women’s imaging encompasses many radiology procedures related to women and the diseases that are most prevalent to women such as breast cancer or gynecological issues. Mammogram, breast ultrasound, breast MRI and breast biopsy are the most commonly used procedures.
American College of Radiology Chief Executive Officer Dana Smetherman, MD, explains the highlights of the recent BI-RADS Version 2025 release, the first update in more than a decade.
The new policy applies to all health plans across Pennsylvania, New York, West Virginia and Delaware, “removing financial barriers for essential breast cancer diagnostics.”
The group was recently asked to provide input on a new set of recommendations for image-guided biopsies of suspicious breast lesions—offering providers clarity on key clinical scenarios.
Published Friday in JAMA, scientists recently explored a risk-based mammography tactic that tailors regular imaging regimens to each individual’s danger of developing the disease.
The responses of 1,948 women aged 40 to 49 were detailed recently in Academic Radiology, where researchers offered detailed insight into what factors influence women at average risk of breast cancer to seek or delay screening at certain ages.
This image gallery shows what the various clinical presentations associated with the COVID-19 virus that have been documented during the coronavirus pandemic.
The FDA’s Center for Devices and Radiological Health (CDRH) has updated the status of two previously disaccredited mammography operations, rehabilitating the reputation of one while showing the other in limbo.
Since 2006, the FDA has recommended MRI screenings as a way to detect asymptomatic breast implant ruptures—but many patients seem unaware of or are actively ignoring the guidance.
Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals.